METTE KIRSTINE AGGER

Profile

First Name

: METTE

Middle Name

: KIRSTINE

Last Name

: AGGER

Related Companies

Titles

Company Name

Related People

DIRECTOR

ROBERT M BRENNER, ROBERT M. BRENNER, SCOTT CANUTE, THOMAS DRYBERG, THOMAS DYRBERG, GEORGE ELDRIDGE, LUTZ GIEBEL, DAVID GUYER, KEVIN J. HEYECK, CHRISTOF WESTENFELDER, JOHN WIRTHLIN, JOHN B. WIRTHLIN

DIRECTOR

SCPHARMACEUTICALS INC.

METTE AGGER, ABRAHAM CEESAY, DOROTHY COLEMAN, ABHAY GANDHI, TROY IGNELZI, JACK KHATTAR, PIETER MUNTENDAM, KUSH PARMAR, LEONARD SCHAEFFER, JONATHAN SILVERSTEIN

DIRECTOR

TREVI THERAPEUTICS, INC.

JAMES CASSELLA, DOMINICK COLANGELO, LISA DELFINI, CAYCE DENTON, WILLIAM FORBES, JENNIFER L. GOOD, MICHAEL HEFFERNAN, ED MATHERS, EDWARD MATHERS, DAVID MEEKER, ANNIE MITSAK, ERAN NADAV, THOMAS SCIASCIA, THOMAS R. SCIASCIA, CHRIS SEITER, JOSEPH SORRENTINO, OTELLO STAMPACCHIA, ANNE VANLENT

DIRECTOR

CHRISTOPH M. ADAMS, SANDIP AGARWALA, BARBARA DALTON, JAMES MCARTHUR, DAVID MOTT, SARA NAYEEM

DIRECTOR

TIBURIO THERAPEUTICS INC.

CHRISTOPH M. ADAMS, SANDIP AGARWALA, ABRAHAM N. CEESAY, JAMES G. MCARTHUR, DAVID MOTT, SARA NAYEEM

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2019-03-15

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2018-12-20

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2017-07-14

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2017-09-28

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2017-07-14

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2016-04-13

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2016-01-21

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2014-03-24

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2012-03-29

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2012-03-29